Metabolic Therapy and PSA Trajectory — A Case Study in Slowed Progression (Gleason 8 / Grade Group 5)

Overview & PSA Data

Diagnosis: Prostate cancer, Gleason 8 / Grade Group 5
Therapy: Non-standard metabolic protocol (nutritional ketosis + targeted metabolic modulators)
Purpose: Compare actual PSA progression to the natural, untreated course for high-grade disease.

Date	Interval	PSA (Actual)	PSA (Projected No-Protocol)	Est. PSA Doubling Time
Jan 8 2024	—	32.2	32.2	—
Feb 7 2024	+1 mo	34.7	≈64	—
Sep 24 2024	+8 mo	39.7	≈512	~3.4 yrs (segment est.)
Oct 29 2025	+13 mo	62.1	>4,000	~14 mo (segment est.)

Jan → Sep 2024: +7.5 ng/mL over 8 months (~0.94 ng/mL/mo). |
Sep 2024 → Oct 2025: +22.4 ng/mL over 13 months (~1.72 ng/mL/mo).
Compared with typical high-grade disease (PSA doubling every ~3–4 months), the observed tempo is markedly slower.

Comparative PSA Analysis

In a typical untreated Gleason 8 case, PSA rises exponentially — doubling every 3–4 months and often exceeding 4,000 ng/mL within two years.
Under my metabolic protocol, PSA rose modestly from 32 to 62 ng/mL over 22 months (1.9× increase).
This represents roughly a 4–5× slower biological tempo than expected in the natural course of this disease.

The data suggest that while absolute PSA increased, the underlying tumor kinetics were significantly restrained — implying durable metabolic control rather than unchecked progression.

Statistical and Expected “State of Being” Without Intervention

Clinical context: Median survival (untreated Gleason 8): ~3–6 years. Typical PSA doubling: 3–4 months. Expected PSA after ~20 months: >4,000 ng/mL.

Expected condition by ~24 months without therapy: Widespread skeletal metastases on PSMA PET / bone scan; anemia, fatigue, cachexia; bone pain (pelvis, spine, ribs); PSA often >1,000–5,000 ng/mL; ECOG 2–3 (limited self-care).

Actual condition: Full functional status (ECOG 0); lean, metabolically strong, cognitively clear; stable body weight and energy; no systemic symptoms.

Interpretation: Despite an upward PSA, the disease tempo appears slowed ≈ 5× relative to natural history — suggesting prolonged metabolic control with preserved quality of life.

📄 Download the Full Case Summary (PDF)